Promising early results from the first human clinical trials with new HIV germline-targeting vaccines were reported. These ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Researchers traced a genetic mutation that provides resistance to HIV back to a single individual near the Black Sea 6,700 to ...

The use of nucleoside reverse transcriptase inhibitors, but not other HIV medicines, is linked to a reduced risk for ...

A memorial garden dedicated to those who are living with HIV or have lost their lives to AIDS has been officially opened in ...

A genetic mutation that helps protect against HIV infection has been traced back to a single individual who lived near the ...

Source: VP Chiwenga mourns former PS Sikipa – herald Mukudzei Chingwere Herald Reporter VICE President Dr Constantino ...

Chris Pazdernik says musical theater is his favorite thing in the world. The only thing better is the opportunity to spend a ...

In response to rising sexually transmitted infection (STI) rates and challenges accessing care, the Alabama Department of ...

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus.

Worldwide, an estimated 40 million people live with HIV. Two-thirds of this group on the African continent. In 2023, more ...

Gilead Sciences’ long-acting drug to block HIV has the potential to end the AIDS epidemic worldwide. But accessibility ...